CIDEA and bladder transitional cell carcinoma: Aside from ESCC, public database results also showed that CIDEA was down-regulated in other malignant tumor types such as bladder urothelial carcinoma (BLCA), breast invasive carcinoma (BRCA), glioblastoma multiforme (GBM), head and neck squamous cell carcinoma (HNSC).